Search

Your search keyword '"Tieghi A."' showing total 1,544 results

Search Constraints

Start Over You searched for: Author "Tieghi A." Remove constraint Author: "Tieghi A."
1,544 results on '"Tieghi A."'

Search Results

3. Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib

6. Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib

7. Design of Sinusoidal Leading Edge for Low-Speed Axial Fans Operating under Inflow Distortion

8. P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTENSIVE CHEMOTHERAPY IMPACTS ON THE LEVEL OF POST-CONSOLIDATION MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA

9. P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MONOTHERAPY: PREDICTORS OF EARLY DISCONTINUATION AND DEATH ON TREATMENT. THE SHORT-TERM RUX PROGNOSTIC MODEL (STR-PM)

10. A Machine Learning Algorithm Applied to Trichoscopy for Androgenic Alopecia Staging and Severity Assessment

11. Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020

20. Effectiveness of a Protocol with Antimicrobial Photodynamic Therapy for Treating Osteoradionecrosis: A Retrospective Study

21. Flash flood prediction in St. Lucia island through a surrogate hydraulic model.

22. Surrogate Modeling of the Aeroacoustics of an NM80 Wind Turbine

23. A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis

27. Cirurgia Guiada para Instalação de Implantes em Paciente Submetido à Radioterapia em Região de Cabeça e Pescoço

28. Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study

29. Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial

31. Use of Remdesivir in Patients with SARS-CoV-2 Pneumonia in a Real-Life Setting during the Second and Third COVID-19 Epidemic Waves

32. Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use

33. Leading Edge Bumps for Flow Control in Air-Cooled Condensers

34. Diagnostic accuracy and interobserver variability of CO-RADS in patients with suspected coronavirus disease-2019: a multireader validation study

35. Characterization of High-Pressure Hydrogen Leakages.

36. Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

37. Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy

39. A Case Report of Monkeypox in an Adult Patient from Italy: Clinical and Dermoscopic Manifestations, Diagnosis and Management

40. P1010: RUXOLITINIB IN MYELODEPLETIVE MYELOFIBROSIS: RESPONSE, TOXICITY, AND OUTCOME

41. P1011: PREDICTORS OF COVID-19 DISEASE AND SURVIVAL TO COVID-19 IN MPN PATIENTS TREATED WITH RUXOLITINIB

42. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

44. Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects

45. The Mediator Effect of Personality on the Relationship Between Symptomatic Impairment and Treatment Outcome in Eating Disorders

46. Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.

47. Aerodynamics and Aeroacoustics of Leading Edge Serration in Low-Speed Axial Fans With Forward Skewed Blades.

49. A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis

50. Steroid use in measles: A retrospective cohort study during the 2017 outbreak in tertiary referral center, Rome and Latina, Italy

Catalog

Books, media, physical & digital resources